Improve medical instruments released the investor relations activity record, and the company has not yet obtained more information about the investigation and detention of the chairman. The participating subsidiary company, Hangzhou Kangda Sisri Biotechnology Co., Ltd., is a foreign-invested enterprise mainly engaged in the research, development, production, sales, and technical services of POCT molecular diagnostic instruments and supporting reagent products, with no business involving human stem cells.